On October 18th, 2023, at the Demo Day hosted by Honsun Precision Industry Co., Ltd. and H. Spectrum+, Pharmasaga, represented by CEO Ivan Chen, stood out from 183 submissions. The Company was selected as a strategic partner for Honsun Precision's expansion into the pharmaceutical sector.
!!! HAPPENING TODAY !!! The grandest biotech exhibition in Asia, BIO Asia 2022, has officially commenced on July 28th! We have already welcomed many distinguished guests to Pharmasaga's booth.
The Ministry of Science and Technology (MoST) led 14 top-tier Taiwanese biomedical startups to the BIO International Convention (US BIO), held in San Diego, USA, from June 13th to 16th. On the 15th, the MoST's Department of Industry-Academia Collaboration hosted a local Smart Health Demo Day to facilitate networking and matching...
Health Medical News/Reporter 林怡亭, Friday, June 10, 2022, 9:00 AM
By Keoni Everington, Taiwan News, Staff Writer2021/09/23 18:33
Diabetes has remained incurable for two millennia, primarily because patients lose the number and function of their pancreatic beta-cells during the disease progression. Consequently, diabetic patients are often forced to rely on insulin injections for survival.
薛宜家 林志堅 / Taipei Report ; Published：2021-09-23 12:56 Updated : 2021-09-23 14:43
2021/9/23 12:51 (Updated 9/23 13:21)
A team from Academia Sinica's Agricultural Biotechnology Center has discovered a gene that, if overexpressed, leads to the failure of pancreatic beta-cells. Consequently, late-stage diabetic patients must rely solely on insulin injections to slow the progression of the disease. However, now that the mechanism of this gene is understood, they have...
The current situation where diabetes is considered incurable is set to be reversed! A team led by Dr. Wen-Ching Yang, a research fellow at the Agricultural Biotechnology Research Center of Academia Sinica, discovered through mouse experiments that Pdia4 (Protein Disulfide Isomerase) is responsible for regulating pancreatic beta-cells. By using the...
